Insights Into Recovery From Acute Fulminant Myocarditis Following Successful Treatment With Ruxolitinib by Comprehensive Single-Cell Profiling
- 24 June 2025
- journal article
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (25) , 1814-1817
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Diagnosis and Treatment of Acute MyocarditisJAMA, 2023
- Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor MyocarditisCancer Discovery, 2023
- The JAK-STAT pathway at 30: Much learned, much more to doCell, 2022
- Single-cell multi-omics analysis of the immune response in COVID-19Nature Medicine, 2021
- Recognition and Initial Management of Fulminant MyocarditisCirculation, 2020